Overall, FZD7 expression was higher for the NAFLD subjects in comparison with controls, while moderate NAFLD patients presented a lower FDZ7 expression than the severe ones. The gene discussed is FZD7; the disease is metabolic dysfunction-associated steatotic liver disease.